CVC Capital Partners Limited Company Profile

21:25 EDT 18th March 2018 | BioPortfolio



6th Floor, 111 Strand
United Kingdom


Phone: 020 7420 4200
Fax: 020 7420 4233

News Articles [1257 Associated News Articles listed on BioPortfolio]

Centrexion raises $67mm in Series D round to fund Phase III trial for pain candidate CNTX4975

Pain-focused Centrexion Therapeutics Corp. raised $67mm in a Series D financing led by New Enterprise Associates. New and returning investors, including Quan Capital, ArrowMark Partners, investment fu...

Honest Buildings Expands Series B Round to $21M with Additional Real Estate-Owner Investments

They join existing Series B industry investors Brookfield Property Partners, Rudin Ventures and C-III Capital Partners, in addition to leading venture capital funds Navitas Capital, Read more...

Medigene-Aktie: Short-Attacke von Leerverkäufer GSA Capital Partners geht weiter - Aktiennews

Martinsried - Leerverkäufer GSA Capital Partners LLP erhöht Netto-Leerverkaufsposition in Medigene-Aktien signifikant: Die Leerverkäufer des Hedgefonds GSA Capital Partners LLP setzen ihre Short-At...

M&As this week: Crescent Capital Partners, IPCA Laboratories Ltd

Crescent Capital Partners has acquired Nucleus Network Ltd from Baker IDI Heart and Diabetes Institute. The sale will help Baker...Read More... The post M&As this week: Crescent Capital Partners, ...

Medigene-Aktie: Leerverkäufer GSA Capital Partners hat den Rückwärtsgang eingelegt!

Martinsried - Leerverkäufer GSA Capital Partners LLP baut Netto-Leerverkaufsposition in Medigene-Aktien etwas ab: Die Leerverkäufer des Hedgefonds GSA Capital Partners LLP haben den Rückwärtsgang ...

M&As this week: Court Square Capital Partners, Quotient Sciences Limited, Jinzi Ham

Court Square Capital Partners has acquired a majority stake in clinical research organisation Celerion Holdings from MTS Health Investors. Both Court...Read More... The post M&As this week: Court...

Paul Capital Partners: Financing and Risk Sharing

In this episode of PharmaTelevision News Review, Fintan Walton talks with Ken MacLeod, Partner at Paul Capital Partners. Filmed at BioTrinity 2010 in Newbury, UK.

Semma's Series B brings in $114mm

Three-year-old regenerative medicine firm Semma Therapeutics Inc. raised $114mm in an oversubscribed Series B financing co-led by Eight Roads Ventures and Cowen Healthcare Investments, which each add ...

PubMed Articles [360 Associated PubMed Articles listed on BioPortfolio]

A Tale of Two Towns: A Comparative Study Exploring the Possibilities and Pitfalls of Social Capital among People Seeking Recovery from Substance Misuse.

Social capital has become an influential concept in debating and understanding the modern world. Within the drug and alcohol sector, the concept of 'recovery capital' has gained traction with research...

Changes in social capital and depressive states of middle-aged adults in Japan.

The present study examines the relationships between changes in bonding and bridging types of social capital and depressive states among middle-aged adults in Japan using a nationally representative s...

Recovery capital pathways: Modelling the components of recovery wellbeing.

In recent years, there has been recognition that recovery is a journey that involves the growth of recovery capital. Thus, recovery capital has become a commonly used term in addiction treatment and r...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

Clinical Trials [310 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

Companies [1904 Associated Companies listed on BioPortfolio]

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

Amulet Capital Partners, LP

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long...

Heritage Group LLC

Heritage Group is a unique venture capital firm with a track record of investing in, operating and advising innovative industry leading healthcare companies. Heritage Group serves...


VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "CVC Capital Partners Limited" on BioPortfolio

We have published hundreds of CVC Capital Partners Limited news stories on BioPortfolio along with dozens of CVC Capital Partners Limited Clinical Trials and PubMed Articles about CVC Capital Partners Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CVC Capital Partners Limited Companies in our database. You can also find out about relevant CVC Capital Partners Limited Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record